Trial Profile
Study for evaluation of safety and efficacy of a pre-seasonal immunotherapy with an allergoid preparation of an extract of 6 grass pollen mixture in pts with a clinically relevant grass pollen sensitivity
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Jul 2005
Price :
$35
*
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Grass pollen hypersensitivity; Rhinoconjunctivitis
- Focus Therapeutic Use
- 25 Jul 2005 New trial record.